Bioequivalence and Bioavailability Forum

Subject	Category	Author	posted	Replies	last R.	Views
updates of installation bear with macOS (Mojave) upgrade R with macOS (Mojave) an old itch when running RGtk2 (GUI) with macOS upgrade/re-install cairoDevice package from source (macOS)	R for BE/BA	yjlee168	2019-07-08 10:15	3	2019-08-11 20:29	746
Sample size calculation for NTI molecules PowerTOST: sampleN.NTIDFDA()	Power / Sample Size	narra1813	2019-08-10 09:21	1	2019-08-10 11:23	385
NTI drug Bioequivalence study Statistical approach Cherry-picking? digging out the possible reasons of the failure Fed state: T higher variable than R	Study Assessment	Sukalpa Biswas	2019-08-06 09:15	3	2019-08-09 12:36	524
Group by sequence interaction Group by sequence interaction, an urban myth? pristine, genuine, holy, magnificent, inexplicable beautiful variation I love your subject line!	General Statistics	Mutasim	2019-08-07 13:16	3	2019-08-08 10:31	450
Sponsor’s Medical Expert in Bioequivalence Study What’s a “Sponsor’s Medical Expert”?	Regulatives / Guidelines	yatish gosai	2019-08-06 14:29	1	2019-08-07 12:05	394
R-Code for 2×2 Bioequivalence study R-Code for 2×2 Bioequivalence study R-Code for 2×2 Bioequivalence study Why not package bear? Why not package bear? Why not package bear? how to build bear yourself from source tarball R: warning ≠ error	R for BE/BA	sury	2019-08-05 12:30	7	2019-08-06 12:35	620
suggest suitable Sequence for Reference replicate and Two Different Test? Not sure whether it makes sense Not sure whether it makes sense Not sure whether it makes sense Not sure whether it makes sense	Design Issues	SP	2019-07-29 14:31	4	2019-08-05 09:27	525
Free and total analyte to be measure in biological fluid Free and total analyte Free and total analyte Free and total analyte Free and total analyte Free and total analyte	Bioanalytics	Mithu	2019-07-23 07:11	5	2019-08-03 10:41	651
Phoenix 8.1 Phoenix 8.2	Software	Helmut	2018-06-19 01:43	1	2019-08-01 21:36	994
intra subject variation indapamide modified release intra subject variation indapamide modified release intra subject variation indapamide modified release	Power / Sample Size	natiye	2019-07-25 19:29	2	2019-07-29 13:48	400
Call me stupid if you think so... Call me stupid if you think so... Call me stupid if you think so... Call me stupid if you think so...	Study Assessment	jag009	2019-07-27 04:43	3	2019-07-28 21:58	486
Good News, Bad News Good News only Good News only, but not according to some ’Some’ should read the GL (and again, and again) Good News only, but not according to some My stuff My stuff My stuff ≡ Sequence effect Vs Subject effect? Sequence effect Vs Subject effect? Sequence effect Vs Subject effect? Oops!	Study Assessment	Datacollector	2019-07-27 12:09	12	2019-07-28 16:36	956
Biorelevant Dissolution - FeSSGF with Ensure Plus	Dissolution / BCS / IVIVC	thalita_m	2019-07-26 15:55	0		279
BSC approach at each strength? BSC approach at each strength? BSC approach at each strength? BSC approach at each strength? BSC approach at each strength? BCS approach at each strength?	Dissolution / BCS / IVIVC	Mauricio Sampaio	2019-07-19 22:29	5	2019-07-26 15:32	543
Reference Literature Do your homework first	Regulatives / Guidelines	Neil	2019-07-25 18:18	1	2019-07-26 10:42	336